214 related articles for article (PubMed ID: 15663132)
1. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
2. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
McBride E; Marlow LAV; Forster AS; Ridout D; Kitchener H; Patnick J; Waller J
Int J Cancer; 2020 Apr; 146(8):2113-2121. PubMed ID: 31251820
[TBL] [Abstract][Full Text] [Related]
4. Exploring reasons for variations in anxiety after testing positive for human papillomavirus with normal cytology: a comparative qualitative study.
McBride E; Marlow LAV; Bennett KF; Stearns S; Waller J
Psychooncology; 2021 Jan; 30(1):84-92. PubMed ID: 32909308
[TBL] [Abstract][Full Text] [Related]
5. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
6. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
7. 'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
BJOG; 2014 Oct; 121(11):1421-9. PubMed ID: 24690225
[TBL] [Abstract][Full Text] [Related]
8. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
Br J Cancer; 2005 Mar; 92(6):990-4. PubMed ID: 15785734
[TBL] [Abstract][Full Text] [Related]
9. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
Bennett KF; Waller J; McBride E; Forster AS; Di Gessa G; Kitchener H; Marlow L
BJOG; 2021 Mar; 128(4):745-754. PubMed ID: 32783300
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
11. The psychosocial burden of human papillomavirus related disease and screening interventions.
Pirotta M; Ung L; Stein A; Conway EL; Mast TC; Fairley CK; Garland S
Sex Transm Infect; 2009 Dec; 85(7):508-13. PubMed ID: 19703844
[TBL] [Abstract][Full Text] [Related]
12. The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.
Kitchener HC; Fletcher I; Roberts C; Wheeler P; Almonte M; Maguire P
Int J Gynecol Cancer; 2008; 18(4):743-8. PubMed ID: 17944916
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.
McCaffery KJ; Irwig L; Turner R; Chan SF; Macaskill P; Lewicka M; Clarke J; Weisberg E; Barratt A
BMJ; 2010 Feb; 340():b4491. PubMed ID: 20179125
[TBL] [Abstract][Full Text] [Related]
14. The psychosexual impact of testing positive for high-risk cervical human papillomavirus (HPV): A systematic review.
Bennett KF; Waller J; Ryan M; Bailey JV; Marlow LAV
Psychooncology; 2019 Oct; 28(10):1959-1970. PubMed ID: 31411787
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country.
Garcés-Palacio IC; Sanchez GI; Baena Zapata A; Córdoba Sánchez V; Urrea Cosme Y; Rodríguez Zabala D; Ruiz Osorio MA
Psychol Health; 2020 Jun; 35(6):750-769. PubMed ID: 31625399
[No Abstract] [Full Text] [Related]
16. Levels of anxiety and distress following receipt of positive screening tests in Australia's HPV-based cervical screening programme: a cross-sectional survey.
Dodd RH; Mac O; Brotherton JML; Cvejic E; McCaffery KJ
Sex Transm Infect; 2020 May; 96(3):166-172. PubMed ID: 32001660
[TBL] [Abstract][Full Text] [Related]
17. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening.
O'Connor M; O'Leary E; Waller J; Gallagher P; Martin CM; O'Leary JJ; Sharp L;
Prev Med; 2018 Oct; 115():90-96. PubMed ID: 30144488
[TBL] [Abstract][Full Text] [Related]
18. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
[TBL] [Abstract][Full Text] [Related]
19. The effect of being diagnosed with human papillomavirus infection on women's sexual lives.
Alay I; Kaya C; Karaca I; Yildiz S; Baghaki S; Cengiz H; Ekin M; Yasar L
J Med Virol; 2020 Aug; 92(8):1290-1297. PubMed ID: 31696950
[TBL] [Abstract][Full Text] [Related]
20. Sexual Activity, Psychosexual Distress, and Fear of Progression in Women With Human Papillomavirus-Related Premalignant Genital Lesions.
Nagele E; Reich O; Greimel E; Dorfer M; Haas J; Trutnovsky G
J Sex Med; 2016 Feb; 13(2):253-9. PubMed ID: 26782607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
